The 2-Minute Rule for Healthcare News
Novo CEO pressed by Senate to cut costs of obesity, diabetes prescription drugs CEO Lars Fruergaard Jørgensen told lawmakers the company would consider new talks with insurers with regard to the record prices of Wegovy and copyright when they pledge to keep the medicines on their formularies.Sanders swiftly condemned the transfer in a press releas